Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorin K Roskos

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Drug Discovery Today|July 17, 2007
Preclinical and clinical safety of monoclonal antibodiesMohammad A Tabrizi, Lorin K Roskos
CPT: Pharmacometrics & Systems Pharmacology|January 13, 2022
Mechanistic modeling of a human IgG<sub>4</sub> monoclonal antibody (tralokinumab) Fab-arm exchange with endogenous IgG<sub>4</sub> in healthy volunteersBing Wang, Jo Goodman, Lorin K Roskos
Clinical Pharmacokinetics|June 12, 2013
Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosusRajesh Narwal, Lorin K Roskos, Gabriel J Robbie
Journal of Immunological Methods|November 3, 2019
A novel approach to assess domain specificity of anti-drug antibodies to moxetumomab pasudotox, an immunotoxin with two functional domainsInna Vainshtein, Bo Sun, Lorin K Roskos, et al.
Journal of Immunological Methods|January 9, 2017
Immunogenicity assay cut point determination using nonparametric tolerance limitJianchun Zhang, Wenjia Li, Lorin K Roskos, et al.
Clinical Pharmacokinetics|March 12, 2019
Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with AsthmaLi Yan, Bing Wang, Yen Lin Chia, et al.
Drug Discovery Today|February 16, 2006
Elimination mechanisms of therapeutic monoclonal antibodiesMohammad A Tabrizi, Chih-Ming L Tseng, Lorin K Roskos
Journal of Clinical Pharmacology|July 1, 2006
Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjectsLorin K Roskos, Peggy Lum, Pamela Lockbaum, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and childrenGabriel J Robbie, Liang Zhao, John Mondick, et al.
Journal of Pharmaceutical Sciences|April 7, 2004
Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in ratsBing-Bing Yang, Peggy K Lum, Michael M Hayashi, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Drug Discovery Today|July 17, 2007
Preclinical and clinical safety of monoclonal antibodiesMohammad A Tabrizi, Lorin K Roskos
CPT: Pharmacometrics & Systems Pharmacology|January 13, 2022
Mechanistic modeling of a human IgG<sub>4</sub> monoclonal antibody (tralokinumab) Fab-arm exchange with endogenous IgG<sub>4</sub> in healthy volunteersBing Wang, Jo Goodman, Lorin K Roskos
Clinical Pharmacokinetics|June 12, 2013
Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosusRajesh Narwal, Lorin K Roskos, Gabriel J Robbie
Journal of Immunological Methods|November 3, 2019
A novel approach to assess domain specificity of anti-drug antibodies to moxetumomab pasudotox, an immunotoxin with two functional domainsInna Vainshtein, Bo Sun, Lorin K Roskos, et al.
Journal of Immunological Methods|January 9, 2017
Immunogenicity assay cut point determination using nonparametric tolerance limitJianchun Zhang, Wenjia Li, Lorin K Roskos, et al.
Clinical Pharmacokinetics|March 12, 2019
Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with AsthmaLi Yan, Bing Wang, Yen Lin Chia, et al.
Drug Discovery Today|February 16, 2006
Elimination mechanisms of therapeutic monoclonal antibodiesMohammad A Tabrizi, Chih-Ming L Tseng, Lorin K Roskos
Journal of Clinical Pharmacology|July 1, 2006
Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjectsLorin K Roskos, Peggy Lum, Pamela Lockbaum, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and childrenGabriel J Robbie, Liang Zhao, John Mondick, et al.
Journal of Pharmaceutical Sciences|April 7, 2004
Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in ratsBing-Bing Yang, Peggy K Lum, Michael M Hayashi, et al.
Pageof 4